Triều Tiên ghi nhận hơn 2 triệu trường hợp sốt, nghi mắc COVID-19

Ngày 20/5, Triều Tiên đã ghi nhận thêm hơn 260.000 ca nghi mắc COVID-19, nâng tổng số trường hợp có triệu chứng sốt tại nước này lên hơn 2 triệu ca trong bối cảnh dịch COVID-19 bùng phát.

w6Dhu5PhurXhurfhu4vhu6Fk4bu14bu1IOG6sXnhu7bhu5nhu7fhu6Fq4bqx4bqh4bu24buz4buZw7Lhu7nhurfhu7bhu5lvceG6t+G7keG7k+G7meG6t3Hhu5NoceG6t+G7k+G7sXHhurfDouG6t+G7t+G7s+G7meG7jeG7ueG6t+G7t+G7s8OD4buvceG7keG6t+G7k3Z54bq34bu14bun4bu3N+G6t3Hhu5Hhu5Phu5nhurdww6rhu4vhurfhu4pSLuG7mOG7iC3hurVjw6Av4buT4bq14bqhw6B54bq34buL4buhZOG7teG7tSDhurF5w4xy4buJ4bqm4bqx4bqhw6Dhu5lw4buR4bq34buL4buhZOG7teG7tSDhurHhu4tw4bu1LXnhu5Ny4bu3cuG6seG6t+G7t+G7meG7t+G7oWog4bqx4bu24buz4buZw7Lhu7nhurfhu7bhu5lvceG6t+G7keG7k+G7meG6t3Hhu5NoceG6t+G7k+G7sXHhurfDouG6t+G7t+G7s+G7meG7jeG7ueG6t+G7t+G7s8OD4buvceG7keG6t+G7k3Z54bq34bu14bun4bu3N+G6t3Hhu5Hhu5Phu5nhurdww6rhu4vhurfhu4pSLuG7mOG7iC3hurVj4bq34buT4buXceG7k+G6t+G6uXHhu5PhurfhurXhurHhurfhu7Xhu7Phu4sg4bqxLy/hu4s44buJ4buT4buLcTjhurRxL+G7mXDhu5Ev4buJauG7teG7n+G7t3J5L+G7iS3DrGRy4bu34buTZHHhu5Phu5NyZDjhurRxL3Fqw4Lhu7Uvw6LDosOi4bqzL+G6teG6q+G6q+G7ieG6reG6s2LhuqfDouG6p+G6teG7t+G6teG6reG6p+G6qeG7oeG6tTjDgmrDrHnhurHhurdk4buh4bu3IOG6seG7tuG7s+G7mcOy4bu54bq34bu24buZb3Hhurfhu5Hhu5Phu5nhurdx4buTaHHhurfhu5Phu7Fx4bq3w6Lhurfhu7fhu7Phu5nhu43hu7nhurfhu7fhu7PDg+G7r3Hhu5Hhurfhu5N2eeG6t+G7teG7p+G7tzfhurdx4buR4buT4buZ4bq3cMOq4buL4bq34buKUi7hu5jhu4gt4bq1Y+G6seG6t+G7iWThu7dkLXnhu5Ny4bu3ci1y4buz4buZ4buR4buZcWThu6Et4bu14buz4buLIOG6seG7k+G7t+G7t3nhu7U1Ly/hu4vhu4lx4buZcOG7kTjhurThu5lq4bu3cWRweeG7oeG7ueG7tTjhurRxL+G7t+G6qcOi4bqzL+G7uXnhu6FyZOG7iWrhu4kveeG7i8O0ci/DouG6s8Oiw6Jf4bqz4bqtX8Oi4bqzL+G7t+G7t+G6pOG6tHFfw6LhurPhurPhuq1f4bu34buz4buZauG7uV/hu7fhu5lqcTjhu6N54buR4bqx4bq3L+G6oVHhu5Phu4Vx4bq34bq04buZb3Hhurfhuqbhurfhu7fDs+G6t3nhu5Phu7lx4bq34buf4buT4bq24bq34buf4buT4bu5aXHhurd54buTdHHhu5Hhurfhu4vhu5Phu6dx4buR4bq34buJxqHhu4vhu5Phurfhu4pSLuG7mOG7iC3hurVj4bq34bu3w6nhu5nhurdwxrDhu7fhurfhu4vhurZk4bq34buTZXHhu5Hhurd34bq3w4zhu5dx4buT4bq3UeG7k8ODeHHhu5E34bq34bu24buz4buZw7Lhu7nhurfhu7bhu5lvcTjhurdh4bq4ceG7kzXhurdEw5RZL+G7tuG7tiguUcOhw6AveeG6ocOgeeG6t+G7i+G7oWThu7Xhu7Ug4bqxeeG7kmpk4buJ4bqx4bqhUeG7kWXhuqbhurfDouG6sy/huq034bq34bu24buz4buZw7Lhu7nhurfhu7bhu5lvceG6t8Sp4bq74bq34buR4buT4buZ4bq3ceG7k2hx4bq34bu34buTb3Dhurfhu5Phu7Fx4bq3w6LhuqnhurM44bqz4bqz4bqz4bq34buLZOG6t3Hhu5Hhu5Phu5nhurdww6rhu4vhurfhu4pSLuG7mOG7iC3hurVjN+G6t3Hhu4Vx4buR4bq34bu34bupceG7keG6t+G7teG7p+G6t+G7t+G7s8OD4buvceG7keG6t+G7k3Z54bq34buLc+G6t+G7t+G7s+G7meG7jeG7ueG6t+G7i+G7k8SCceG7keG6t+G7teG7p+G7t+G6t+G7t8Op4buZ4bq3ccOD4but4buL4bq3cWXhuqbhurfhu6FvceG6t+G7k+G7sXHhurfDouG6t+G7t+G7s+G7meG7jeG7ueG6t+G7i2Thurfhu7fhu7NyceG7keG6t8Os4bun4buZ4bq34buL4bq5ceG7k+G6t+G7icah4buL4buT4bq34buKUi7hu5jhu4gt4bq1Y+G6t8Osw4Fx4buR4bq3eeG7k8SR4bu3OMOgL3nhuqHDoHnhurfhu4vhu6Fk4bu14bu1IOG6sXnDjHLhu4nhuqbhurHhuqHhu5Lhurtx4buR4bq34bu34buT4bulceG7keG6t+G7t2Zx4bq34bu34buz4bu5ceG7keG6t8OD4buxceG7keG6t+G7tuG7s+G7mcOy4bu54bq34bu24buZb3Hhurdh4bue4buKUUTDoeG6t+G7icOtceG6t+G7teG7p+G6t+G7oeG7meG7jeG7ueG6t+G7t+G6ruG6t+G7t+G7s8OA4bq34bu1d+G6t3nhu5N0ceG7keG6t+G7i+G7k+G7p3Hhu5Hhurfhu4nGoeG7i+G7k+G6t8Os4buNceG7k+G6t+G7n+G7k2lx4bq34buLZnnhurdx4buTZeG6t3HDg+G7reG7i+G6t+G7i+G7k3LhurfDrOG7mcOz4bu3N+G6t+G7k+G7sXHhurfDouG6qeG6pTjhuqXhuqvhurPhurdx4buRw4Phu6/hu5nhurfhu4tz4bq34bu34buz4buZ4buN4bu54bq34buL4buTxIJx4buR4bq34bu14bun4bu34bq34bq0ZeG6t8Oi4bq34buLZOG6t+G7t+G6tuG6t+G6tHJx4buR4bq3xKnDg3bhu4vhurfhu5Hhu5Phu5nhurdx4buTaHHhurfhu7fhu7NyceG7keG6t+G6tHRx4buR4bq3w6Lhuqfhurfhu5Hhu5nhu6/hurfDveG7uWQ34bq34bu34buVceG7k+G6t+G7t+G7reG7meG6t+G6tWLhurfhu5Hhu5nhu6/hurdx4buRZeG6puG6t+G6tWMv4bqtN+G6t3Hhu4Vx4buR4bq34bu34bupceG7keG6t+G7teG7p+G6t+G7i2Thurfhu7fhurbhurfhurRyceG7keG6t+G7oW9x4bq34bu34buTZXHhu5Phurfhuqnhuq3hurfhu7fhu7PDg+G7r3Hhu5Hhurfhu5N2eTjDoC954bqhw6B54bq34buL4buhZOG7teG7tSDhurF5w4xy4buJ4bqm4bqx4bqh4bu24buTanLhurfhu57hu4pRRDfhurfhu7fhu5Vx4buT4bq34bu34but4buZ4bq34bq1YuG6t+G7keG7meG7r+G6t3Hhu5Fl4bqm4bq34bq1Yy/huq034bq34bu34bupceG7keG6t+G7teG7p+G6t+G7t+G7s8OD4buvceG7keG6t+G7k3Z54bq34buLc+G6t+G7t+G7s+G7meG7jeG7ueG6t+G7i+G7k8SCceG7keG6t+G7teG7p+G7t+G6t8Spw4N24buL4bq34buR4buT4buZ4bq3ceG7k2hx4bq34bu34bqu4bq34buL4bu54bun4buZ4bq34bu34buTxJFx4buR4bq34bqn4bq34buhZeG6t+G7k+G7sXHhurfDojfDouG6p+G6t+G7t+G7s+G7meG7jeG7ueG6t3Hhu5HDg+G7r+G7mTfhurfhu7fhu7NyceG7keG6t8Spc+G6t+G7k+G7sXHhurfhurU34bqnYuG6t+G7t+G7s+G7meG7jeG7ueG6t3Hhu5HDg+G7r+G7meG6t8Sp4bq74bq34buTxanhu5nhurd54buTw4Dhu4s34bq34bu34buzcnHhu5Hhurfhu5/hu5Phu5nhurfhu5Xhu7fhurdx4buTZuG7t+G6t+G6q+G6reG6pzhi4bq14bqz4bq34bu34buzw4Phu69x4buR4bq34buTdnnhurfEqWRx4buR4bq3xKnDg3bhu4vhurfEqeG7mcOy4bu54bq34bu34buzxqE4LzjDoC954bqhw6B54bq34buL4buhZOG7teG7tSDhurF5ROG7ueG7t+G7k3Lhu7PhurHhuqFhLuG7mWrhu7dxZHArw6HDoC954bqh

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh